Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

A group of Boston-area health institutions, known as the Boston Autologous Islet Replacement Program, are teaming up to develop, test and deploy stem cells to cure diabetes. The group includes the Harvard Stem Cell Institute, Brigham and Women's Hospital, the Joslin Diabetes Center, Dana-Farber Cancer Institute and Semma Therapeutics. The innovation began when Doug Melton, Co-Director …

Continue reading Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

Whitehead Institute Corrects Disease-Causing Mutations in Stem Cells

On July 14th, MBBP client Whitehead Institute for Biomedical Research announced its researchers have successfully manipulated targeted genes in both human embryonic stem cells and induced pluripotent stem cells. Scientists working on this project published a paper in the July 22 issue of the journal Cell that describes two methods for either inserting or removing …

Continue reading Whitehead Institute Corrects Disease-Causing Mutations in Stem Cells